glp 1 agonist dpp 4 inhibitor GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? Mechanism of action for GIP,

Why wouldnt Eliquis or Pradaxa (which do not appear to be the lowest cost option in Canada) forgo participating in the Ontario market

GLP-1- based treatments for T2DM, such as GLP-1 receptor agonists, dual and triple agonists that activate GLP-1R, GIPR, and glucagon receptors, and dipeptidyl peptidase-4 (DPP-4) inhibitors have been reviewed here

Gromada, J., Holst, J

SURMOUNT-4 will address the question of weight regain after stopping the drug: patients who took tirzepatide for 6 months, will be assessed for sustained weight loss one year later (NCT04660643)

2.2.5 Metabolic reprogramming Metabolic reprogramming refers to the process in which cells, under specific physiological and pathological conditions, systematically adjust and transform their metabolic patterns to adapt to changes in the external environment and to meet their own needs for growth and differentiation, by engaging various bioenergetic routes, such as glucose utilization, lipid metabolism, and amino acid metabolism (Xia et al., 2021

Li Y, Wang Y, Wei Q, et al